FDA Risk Communication Advisory Cmte. Will Assess Pharmacy Leaflets’ Utility
Executive Summary
FDA's Risk Communication Advisory Committee will meet Feb. 26-27 to discuss how to improve the usability of consumer medical information leaflets distributed by pharmacies with prescription drugs
You may also be interested in...
Single Patient Drug Leaflet Logical, Complicated To Achieve - Woodcock
FDA officials are leaning toward a single document to inform patients about their medications, but whether and how that can be accomplished remain unanswered questions
Single Patient Drug Leaflet Logical, Complicated To Achieve - Woodcock
FDA officials are leaning toward a single document to inform patients about their medications, but whether and how that can be accomplished remain unanswered questions
FDA Prepares Prototypes Of Consumer Medical Information Options
Workshop in September will gather input on how to ensure patients understand both risks and benefits.